CLINICAL RESEARCH
The relationship between demographic and anthropometric characteristics and diabetic complications and number of hospitalizations in hospitalized diabetic patients
Submission date: 2018-09-18
Final revision date: 2019-01-07
Acceptance date: 2019-01-07
Publication date: 2019-01-22
Arch Med Sci Civil Dis 2019;4(1):7-15
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Diabetes mellitus is the most common endocrine disease in the world. A total of 371 million people with diabetes lived in the world in 2012, 4.8 million people lost their lives due to diabetes, and 612–1099 billion dollars are spent on diabetic patients each year. The aim of our study was to investigate the relationship between the number of hospitalized patients, the demographic and anthropometric characteristics, and diabetic complications.
Material and methods:
Five hundred patients hospitalized with DM diagnosis were included in this study. Patients were divided into three groups according to the number of hospitalizations. The relationship between the number of hospitalizations and risk factors was examined. Parameters were analyzed using linear regression, 2 test and independent t-test.
Results:
When the number of hospitalizations was classified, the groups were formed as the patients who were hospitalized once, twice, or three times or more, respectively: 351 (70.2%), 86 (17.2%), and 63 (12.6%). In our study, it was found that patients with three times or more hospitalizations had worse glycemic control, duration of diabetes, and rate of taking insulin treatment, which was found to be significantly high (p < 0.05), the number of non-smokers was significantly low (p < 0.05), the quitting rate was significantly high (p < 0.05), nephropathy, retinopathy, and cerebrovascular events and cardiovascular diseases were significantly high (p < 0.05) compared to one and two hospitalizations.
Conclusions:
In our study, it was found that glycemic control and diabetic complications were important determinants in the control of diabetes-related hospitalizations; and well-controlled diabetes was found to reduce the number of hospital admissions of patients with diabetes in Turkey. There are no financial data; however, in this context, it can be envisaged that it will have a lowering effect on the cost per patient.
Diabetes mellitus is the most common endocrine disease in the world. A total of 371 million people with diabetes lived in the world in 2012, 4.8 million people lost their lives due to diabetes, and 612–1099 billion dollars are spent on diabetic patients each year. The aim of our study was to investigate the relationship between the number of hospitalized patients, the demographic and anthropometric characteristics, and diabetic complications.
Material and methods:
Five hundred patients hospitalized with DM diagnosis were included in this study. Patients were divided into three groups according to the number of hospitalizations. The relationship between the number of hospitalizations and risk factors was examined. Parameters were analyzed using linear regression, 2 test and independent t-test.
Results:
When the number of hospitalizations was classified, the groups were formed as the patients who were hospitalized once, twice, or three times or more, respectively: 351 (70.2%), 86 (17.2%), and 63 (12.6%). In our study, it was found that patients with three times or more hospitalizations had worse glycemic control, duration of diabetes, and rate of taking insulin treatment, which was found to be significantly high (p < 0.05), the number of non-smokers was significantly low (p < 0.05), the quitting rate was significantly high (p < 0.05), nephropathy, retinopathy, and cerebrovascular events and cardiovascular diseases were significantly high (p < 0.05) compared to one and two hospitalizations.
Conclusions:
In our study, it was found that glycemic control and diabetic complications were important determinants in the control of diabetes-related hospitalizations; and well-controlled diabetes was found to reduce the number of hospital admissions of patients with diabetes in Turkey. There are no financial data; however, in this context, it can be envisaged that it will have a lowering effect on the cost per patient.
REFERENCES (21)
1.
Satman İ, İmamoğlu Ş, Yılmaz C, Akalın S. ve Diyabetes Mellitus Çalışma ve Eğitim Grubu. TEMD Diyabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu, 5. Baskı. Bayt Matbaacılık, Ankara, 2011.
2.
Hilton DJ, O’Rourke PK, Welborn TA, et al. Diabetes detection in Australian general practise: a comparison of diagnostic criteria. Med J Aust 2002; 176: 104-7.
3.
Da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 2016; 117: 48-54.
4.
The TURDEP Group. Population-based study of diabetes and risk characteristics in Turkey. Diabetes Care 2002; 25: 1551-6.
5.
Satman I; the TURDEP Group. Population-Based Study of Diabetes and Risk Characteristics in Turkey. 32. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi özet kitabı, Antalya, 2010: 24-9.
6.
Zhaolan L, Chaowei F, Weibing W, et al. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients – a cross-sectional hospital based survey in urban China. Health Qual Life Outcomes 2010; 8: 62.
7.
Rhee SY, Chon S, Kwon MK, et al. Prevalence of chronic complications in Korean patients with type 2 diabetes mellitus based on the Korean National Diabetes Program. Diabetes Metab J 2011; 35: 504-12.
8.
Menzin J, Langley-Hawthor C, Friedman M, et al. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 2001; 24: 51-5.
9.
American Diabetes Association Professional Practice Committee. American Diabetes Association clinical practice recommendations. Diabetes Care 2013; 36 (Suppl 1): 1-110.
10.
International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-34.
11.
American Diabetes Association. Standards of medical care in diabetes 2015. Diabetes Care 2015; 38: 8-67.
12.
Menzin J, Korn JR, Cohen J, et al. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus. J Manag Care Pharm 2010; 16: 264-75.
13.
Gilmer TP, O’Connor PJ, Rush WA, et al. Predictors of health care costs in adults with diabetes. Diabetes Care 2005; 28: 59-64.
14.
Moss SE, Klein R, Klein BE. Risk factors for hospitalization in people with diabetes. Arch Intern Med 1999; 159: 2053-7.
15.
Charron-Prochownik D, Kovacs M, Obrosky DS, et al. Biomedical and psychosocial predictors of early rehospitalization among children with insulin-dependent diabetes mellitus: a longitudinal study. Diabet Med 1994; 11: 372-7.
16.
Kovacs M, Charron-Prochownik D, Obrosky DS. A longitudinal study of biomedical and psychosocial predictors of multiple hospitalizations among young people with insulin-dependent diabetes mellitus. Diabet Med 1995; 12: 142-8.
17.
Jiang HJ, Stryer D, Friedman B, et al. Multiple hospitalizations for patients with diabetes. Diabetes Care 2003; 26: 1421-6.
18.
Shetty S, Secnik K, Oglesby AK. Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes. J Manag Care Pharm 2005; 11: 559-64.
19.
Oglesby AK, Secnik K, Barron J, et al. The association between diabetes-related medical costs and glycemic control: a retrospective analysis. Cost Eff Resour Alloc 2006; 4: 1.
20.
Montori VM, Fernandez-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face. Ann Intern Med 2009; 150: 803-8.
21.
Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765-72.
Share
RELATED ARTICLE
| ISSN: | 2451-0637 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
